Neuralia TMS Delivers Advanced TMS Therapy for OCD Treatment
March 17, 2026Australia, 17th Mar 2026 – Neuralia TMS, a leader in non-invasive neurological treatments, has announced an expansion of its services to include transcranial Direct Current Stimulation (tDCS), an at-home neuromodulation therapy, as well as pharmacogenetic testing to optimise treatment outcomes. Known for…
